Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

Executive Summary

PacificHealth: Second-quarter revenues for PacificHealth Laboratories, Inc. increased 15 percent to $2.37 million compared to $2.07 million in the prior year's period. For the April-June period in its fiscal 2008, the Matawan, N.J.-based firm records a net loss of $146,608 compared to a net loss of $127,276 last year. PacificHealth says its focus has been base business growth and increased efficiency. "Achieving 15 percent revenue growth for the second quarter, moving our gross profit margin from 37.3 percent to 45 percent for the half year, and ongoing working capital improvements is clear evidence that we are executing what we set out to achieve," the firm says. For the first six months of its fiscal year, revenues were $4.09 million compared to $3.88 million for the same period. The firm also says it is planning "significant innovation" in 2009

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel